Reflecting on the learning during the pandemic, industry is aiming to push innovation in R&D and implement automation and digital technologies across various operational levels.
Orbia expects EBITDA to increase between 4 to 7%.
The Group’s performance improved in 2H2020 due to China’s rapidly recovering economy and the auto market’s rebound.
Overall core market conditions for all of the businesses are now positive, particularly in Asia.
Bayer has announced a series of decisions to accelerate the strategy implementation of its Crop Science division.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio and the transaction is expected to close in the second quarter of 2021
These awards are a recognition of the company's commitment to deliver value and support the continued growth across their markets.
The company accelerated its digital transformation and successfully expanded its presence in several parts of the world in 2020.
BASF aims to increase its sales to between €61 billion and €64 billion in 2021.
The tenure is for 7 years including 2 years moratorium period.
.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
The divestment of PMMA is expected to close in mid-year.
Building upon the momentum gained by pharma sector during the pandemic, Indian Pharmaceutical Alliance is leaving no stone unturned to create a faster road to recovery.
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
Total incremental sales of Rs.2,94,000 crore and total incremental exports of Rs.1,96,000 crore are estimated during six years from 2022-23 to 2027-28.
The Govt. launched the PLI scheme for bulk drugs with a financial outlay of Rs 6,940 crores across 53 APIs over 6 years.
Net sales for the full year 2020 were down 10% organically.
Creation of information and communication facilities to help harness the full potential of development in the region
While top industry leaders are optimistic about the growth, they expect the special incentives and regulatory streamlining from the government’s side
The chemical industry’s output is expected to grow by 3% in 2021 and 2% in 2022.
Subscribe To Our Newsletter & Stay Updated
